A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia
Clinical trial NCT05743465 · COMPLETED
Trial details
- NCT number
- NCT05743465
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-06
- Primary completion
- 2022-11-30
- Enrollment
- 1769
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.